Safety and efficacy of single‐agent docetaxel (Taxotere) administered weekly in non‐small cell lung carcinoma patients in Korea: An observational study

Background To investigate the efficacy, safety, and tolerability of weekly docetaxel treatment in advanced non‐small cell lung cancer (NSCLC) patients in Korea. Methods This prospective observational study included Korean advanced NSCLC patients with Eastern Cooperative Oncology Group performance st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thoracic cancer 2016-03, Vol.7 (2), p.207-214
Hauptverfasser:	Lim, Sun Min, Park, Byeong Bae, Park, Keun‐Chil, Kim, Hoon‐Kyo, Lee, Jong Seok, Bae, Sung Hwa, Lee, Seung‐Sei, Kang, Jin‐Hyoung, Park, Se‐Hoon, Lee, Gyeong‐Won, Lee, Hyo‐Rac, Seo, Jae Hong, Kim, Yong Tae, Yang, Sung Hyun, Kim, Joo‐Hang
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimitotic agents Antineoplastic agents Cancer Carcinoma Care and treatment Complications and side effects docetaxel Lung cancer, Non-small cell non‐small cell lung cancer Oncology, Experimental Original safety
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background To investigate the efficacy, safety, and tolerability of weekly docetaxel treatment in advanced non‐small cell lung cancer (NSCLC) patients in Korea. Methods This prospective observational study included Korean advanced NSCLC patients with Eastern Cooperative Oncology Group performance status
ISSN:	1759-7706 1759-7714
DOI:	10.1111/1759-7714.12315